U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06932536) titled 'The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Prescription F1) in Healthy Volunteers' on April 10.
Brief Summary: This is a randomized, double-blind, placebo-controlled phase I bridging study to evaluate the PK, safety and tolerability of SR750 (prescription F1) in Chinese healthy subjects.
Study Start Date: April 21
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: SR750 tablet
Ascending single and multiple doses of SR750 orally
DRUG: Placebo
Ascending single and multiple doses of placebo orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
Published b...